Lymphoseek
Phase 3Completed 1 views this week 0 watching💤 Quiet
Interest: 30/100
30
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Breast Cancer
Conditions
Breast Cancer, Melanoma
Trial Timeline
Apr 1, 2008 → Jul 1, 2009
NCT ID
NCT00671918About Lymphoseek
Lymphoseek is a phase 3 stage product being developed by Navidea Biopharmaceuticals for Breast Cancer. The current trial status is completed. This product is registered under clinical trial identifier NCT00671918. Target conditions include Breast Cancer, Melanoma.
What happened to similar drugs?
20 of 20 similar drugs in Breast Cancer were approved
Approved (20) Terminated (4) Active (0)
Hype Score Breakdown
Clinical
17
Activity
8
Company
5
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01106040 | Phase 3 | Completed |
| NCT00911326 | Phase 3 | Terminated |
| NCT00671918 | Phase 3 | Completed |
Competing Products
20 competing products in Breast Cancer